{"transactions":[{"id":1203065,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2025-03-18T20:36:38.000Z","date":"2025-03-14","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 7, 2017, which was the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":159.32,"expiration_date":"2026-09-07","underlying":"Bio-Rad A Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001062993-25-005730","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299325005730/form4.xml","form_type":"4"}},{"id":1203064,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2025-03-18T20:36:38.000Z","date":"2025-03-14","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":247.0614,"value":741184.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $245.0239 to $249.1550, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":8171,"source":{"system":"sec-edgar","filing":"0001062993-25-005730","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299325005730/form4.xml","form_type":"4"}},{"id":1203063,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2025-03-18T20:36:38.000Z","date":"2025-03-14","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":159.32,"value":477960.0,"ownership":{"direct":true},"balance_after":11171,"source":{"system":"sec-edgar","filing":"0001062993-25-005730","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299325005730/form4.xml","form_type":"4"}},{"id":1411563,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2024-09-10T17:57:28.000Z","date":"2024-09-06","kind":"grant","planned":false,"acquired":true,"shares":3456,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":3456,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":3456},"source":{"system":"sec-edgar","filing":"0001062993-24-016378","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016378/form4.xml","form_type":"4"}},{"id":1414965,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T13:36:10.000Z","date":"2024-09-03","kind":"exercise","planned":false,"acquired":false,"shares":557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":557},"source":{"system":"sec-edgar","filing":"0001062993-24-016196","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016196/form4.xml","form_type":"4"}},{"id":1414964,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T13:36:10.000Z","date":"2024-09-02","kind":"exercise","planned":false,"acquired":false,"shares":434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":434},"source":{"system":"sec-edgar","filing":"0001062993-24-016196","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016196/form4.xml","form_type":"4"}},{"id":1414963,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T13:36:10.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":false,"shares":405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":406,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":405},"source":{"system":"sec-edgar","filing":"0001062993-24-016196","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016196/form4.xml","form_type":"4"}},{"id":1414962,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T13:36:10.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":false,"shares":520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1042,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":520},"source":{"system":"sec-edgar","filing":"0001062993-24-016196","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016196/form4.xml","form_type":"4"}},{"id":1414961,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2024-09-05T13:36:10.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":false,"shares":751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On September 1, 2023, the reporting person was granted 3,005 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On September 1, 2023, the reporting person was granted 3,005 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":2254,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":751},"source":{"system":"sec-edgar","filing":"0001062993-24-016196","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016196/form4.xml","form_type":"4"}},{"id":1414960,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T13:36:10.000Z","date":"2024-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":283,"price":334.31,"value":94609.73,"ownership":{"direct":true},"balance_after":8171,"source":{"system":"sec-edgar","filing":"0001062993-24-016196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016196/form4.xml","form_type":"4"}},{"id":1414959,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T13:36:10.000Z","date":"2024-09-03","kind":"exercise","planned":false,"acquired":true,"shares":557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":8454,"source":{"system":"sec-edgar","filing":"0001062993-24-016196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016196/form4.xml","form_type":"4"}},{"id":1414958,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T13:36:10.000Z","date":"2024-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":155,"price":337.32,"value":52284.6,"ownership":{"direct":true},"balance_after":7897,"source":{"system":"sec-edgar","filing":"0001062993-24-016196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016196/form4.xml","form_type":"4"}},{"id":1414957,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T13:36:10.000Z","date":"2024-09-02","kind":"exercise","planned":false,"acquired":true,"shares":434,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":8052,"source":{"system":"sec-edgar","filing":"0001062993-24-016196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016196/form4.xml","form_type":"4"}},{"id":1414956,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T13:36:10.000Z","date":"2024-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":145,"price":337.32,"value":48911.4,"ownership":{"direct":true},"balance_after":7618,"source":{"system":"sec-edgar","filing":"0001062993-24-016196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016196/form4.xml","form_type":"4"}},{"id":1414955,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T13:36:10.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":true,"shares":405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":7763,"source":{"system":"sec-edgar","filing":"0001062993-24-016196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016196/form4.xml","form_type":"4"}},{"id":1414954,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T13:36:10.000Z","date":"2024-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":218,"price":337.32,"value":73535.76,"ownership":{"direct":true},"balance_after":7358,"source":{"system":"sec-edgar","filing":"0001062993-24-016196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016196/form4.xml","form_type":"4"}},{"id":1414953,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T13:36:10.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":true,"shares":520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":7576,"source":{"system":"sec-edgar","filing":"0001062993-24-016196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016196/form4.xml","form_type":"4"}},{"id":1414952,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T13:36:10.000Z","date":"2024-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":268,"price":337.32,"value":90401.76,"ownership":{"direct":true},"balance_after":7056,"source":{"system":"sec-edgar","filing":"0001062993-24-016196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016196/form4.xml","form_type":"4"}},{"id":1414951,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-09-05T13:36:10.000Z","date":"2024-09-01","kind":"exercise","planned":false,"acquired":true,"shares":751,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":7324,"source":{"system":"sec-edgar","filing":"0001062993-24-016196","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324016196/form4.xml","form_type":"4"}},{"id":1480084,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-06-14T17:42:01.000Z","date":"2024-06-13","kind":"sale","planned":false,"acquired":false,"shares":369,"price":281.9064,"value":104023.4616,"ownership":{"direct":true},"balance_after":6573,"source":{"system":"sec-edgar","filing":"0001062993-24-012628","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324012628/form4.xml","form_type":"4"}},{"id":1583323,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-03-12T16:22:24.000Z","date":"2024-03-08","kind":"grant","planned":false,"acquired":true,"shares":3535,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":3535,"derivative":{"exercise_price":343.76,"expiration_date":"2034-03-08","underlying":"Bio-Rad A Common Stock","underlying_shares":3535},"source":{"system":"sec-edgar","filing":"0001062993-24-006215","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324006215/form4.xml","form_type":"4"}},{"id":1614352,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2024-02-28T23:38:38.000Z","date":"2024-02-27","kind":"exercise","planned":false,"acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 5, 2018, which was the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":215.98,"expiration_date":"2027-09-05","underlying":"Bio-Rad A Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001062993-24-004835","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324004835/form4.xml","form_type":"4"}},{"id":1614351,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-02-28T23:38:38.000Z","date":"2024-02-27","kind":"sale","planned":false,"acquired":false,"shares":3000,"price":336,"value":1008000.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $335.53 to $336.20, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6942,"source":{"system":"sec-edgar","filing":"0001062993-24-004835","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324004835/form4.xml","form_type":"4"}},{"id":1614350,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2024-02-28T23:38:38.000Z","date":"2024-02-27","kind":"exercise","planned":false,"acquired":true,"shares":3000,"price":215.98,"value":647940.0,"ownership":{"direct":true},"balance_after":9942,"source":{"system":"sec-edgar","filing":"0001062993-24-004835","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299324004835/form4.xml","form_type":"4"}},{"id":1729253,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-11-28T22:48:33.000Z","date":"2023-11-28","kind":"sale","planned":false,"acquired":false,"shares":642,"price":305.1,"value":195874.2,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $305.05 to $305.13, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6942,"source":{"system":"sec-edgar","filing":"0001062993-23-021535","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323021535/form4.xml","form_type":"4"}},{"id":1788523,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2023-09-06T17:02:20.000Z","date":"2023-09-04","kind":"exercise","planned":false,"acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F8","text":"On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001062993-23-017646","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":16,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017646/form4.xml","form_type":"4"}},{"id":1788522,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2023-09-06T17:02:20.000Z","date":"2023-09-03","kind":"exercise","planned":false,"acquired":false,"shares":557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F7","text":"On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":557,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":557},"source":{"system":"sec-edgar","filing":"0001062993-23-017646","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017646/form4.xml","form_type":"4"}},{"id":1788521,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2023-09-06T17:02:20.000Z","date":"2023-09-02","kind":"exercise","planned":false,"acquired":false,"shares":433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":434,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":433},"source":{"system":"sec-edgar","filing":"0001062993-23-017646","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017646/form4.xml","form_type":"4"}},{"id":1788520,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2023-09-06T17:02:20.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":false,"shares":405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":811,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":405},"source":{"system":"sec-edgar","filing":"0001062993-23-017646","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017646/form4.xml","form_type":"4"}},{"id":1788519,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2023-09-06T17:02:20.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":false,"shares":520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On September 1, 2022, the reporting person was granted 2,082 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1562,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":520},"source":{"system":"sec-edgar","filing":"0001062993-23-017646","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017646/form4.xml","form_type":"4"}},{"id":1788518,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2023-09-06T17:02:20.000Z","date":"2023-09-01","kind":"grant","planned":false,"acquired":true,"shares":3005,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":3005,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":3005},"source":{"system":"sec-edgar","filing":"0001062993-23-017646","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017646/form4.xml","form_type":"4"}},{"id":1788517,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-09-06T17:02:20.000Z","date":"2023-09-04","kind":"tax_withholding","planned":false,"acquired":false,"shares":298,"price":394.6,"value":117590.8,"ownership":{"direct":true},"balance_after":7584,"source":{"system":"sec-edgar","filing":"0001062993-23-017646","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017646/form4.xml","form_type":"4"}},{"id":1788516,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-09-06T17:02:20.000Z","date":"2023-09-04","kind":"exercise","planned":false,"acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":7882,"source":{"system":"sec-edgar","filing":"0001062993-23-017646","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017646/form4.xml","form_type":"4"}},{"id":1788515,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-09-06T17:02:20.000Z","date":"2023-09-03","kind":"tax_withholding","planned":false,"acquired":false,"shares":202,"price":394.6,"value":79709.2,"ownership":{"direct":true},"balance_after":7282,"source":{"system":"sec-edgar","filing":"0001062993-23-017646","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017646/form4.xml","form_type":"4"}},{"id":1788514,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-09-06T17:02:20.000Z","date":"2023-09-03","kind":"exercise","planned":false,"acquired":true,"shares":557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":7484,"source":{"system":"sec-edgar","filing":"0001062993-23-017646","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017646/form4.xml","form_type":"4"}},{"id":1788513,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-09-06T17:02:20.000Z","date":"2023-09-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":150,"price":394.6,"value":59190.0,"ownership":{"direct":true},"balance_after":6927,"source":{"system":"sec-edgar","filing":"0001062993-23-017646","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017646/form4.xml","form_type":"4"}},{"id":1788512,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-09-06T17:02:20.000Z","date":"2023-09-02","kind":"exercise","planned":false,"acquired":true,"shares":433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":7077,"source":{"system":"sec-edgar","filing":"0001062993-23-017646","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017646/form4.xml","form_type":"4"}},{"id":1788511,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-09-06T17:02:20.000Z","date":"2023-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":141,"price":394.6,"value":55638.6,"ownership":{"direct":true},"balance_after":6644,"source":{"system":"sec-edgar","filing":"0001062993-23-017646","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017646/form4.xml","form_type":"4"}},{"id":1788510,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-09-06T17:02:20.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":true,"shares":405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":6785,"source":{"system":"sec-edgar","filing":"0001062993-23-017646","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017646/form4.xml","form_type":"4"}},{"id":1788509,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-09-06T17:02:20.000Z","date":"2023-09-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":180,"price":394.6,"value":71028.0,"ownership":{"direct":true},"balance_after":6380,"source":{"system":"sec-edgar","filing":"0001062993-23-017646","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017646/form4.xml","form_type":"4"}},{"id":1788508,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-09-06T17:02:20.000Z","date":"2023-09-01","kind":"exercise","planned":false,"acquired":true,"shares":520,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":6560,"source":{"system":"sec-edgar","filing":"0001062993-23-017646","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323017646/form4.xml","form_type":"4"}},{"id":1853704,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2023-06-16T18:02:37.000Z","date":"2023-06-15","kind":"sale","planned":false,"acquired":false,"shares":500,"price":379.39,"value":189695.0,"ownership":{"direct":true},"balance_after":6040,"source":{"system":"sec-edgar","filing":"0001062993-23-013732","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299323013732/form4.xml","form_type":"4"}},{"id":2164833,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2022-09-07T18:07:20.000Z","date":"2022-09-05","kind":"exercise","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"On September 5, 2017, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F6","text":"On September 5, 2017, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001062993-22-019276","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019276/form4.xml","form_type":"4"}},{"id":2164832,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2022-09-07T18:07:20.000Z","date":"2022-09-04","kind":"exercise","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":600,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001062993-22-019276","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019276/form4.xml","form_type":"4"}},{"id":2164831,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2022-09-07T18:07:20.000Z","date":"2022-09-03","kind":"exercise","acquired":false,"shares":557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1114,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":557},"source":{"system":"sec-edgar","filing":"0001062993-22-019276","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019276/form4.xml","form_type":"4"}},{"id":2164830,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2022-09-07T18:07:20.000Z","date":"2022-09-02","kind":"exercise","acquired":false,"shares":433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":867,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":433},"source":{"system":"sec-edgar","filing":"0001062993-22-019276","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019276/form4.xml","form_type":"4"}},{"id":2164829,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:07:20.000Z","date":"2022-09-05","kind":"tax_withholding","acquired":false,"shares":298,"price":478.32,"value":142539.36,"ownership":{"direct":true},"balance_after":6540,"source":{"system":"sec-edgar","filing":"0001062993-22-019276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019276/form4.xml","form_type":"4"}},{"id":2164828,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:07:20.000Z","date":"2022-09-05","kind":"exercise","acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":6838,"source":{"system":"sec-edgar","filing":"0001062993-22-019276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019276/form4.xml","form_type":"4"}},{"id":2164827,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:07:20.000Z","date":"2022-09-04","kind":"tax_withholding","acquired":false,"shares":298,"price":478.32,"value":142539.36,"ownership":{"direct":true},"balance_after":6238,"source":{"system":"sec-edgar","filing":"0001062993-22-019276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019276/form4.xml","form_type":"4"}},{"id":2164826,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:07:20.000Z","date":"2022-09-04","kind":"exercise","acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":6536,"source":{"system":"sec-edgar","filing":"0001062993-22-019276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019276/form4.xml","form_type":"4"}},{"id":2164825,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:07:20.000Z","date":"2022-09-03","kind":"tax_withholding","acquired":false,"shares":241,"price":478.32,"value":115275.12,"ownership":{"direct":true},"balance_after":5936,"source":{"system":"sec-edgar","filing":"0001062993-22-019276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019276/form4.xml","form_type":"4"}},{"id":2164824,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:07:20.000Z","date":"2022-09-03","kind":"exercise","acquired":true,"shares":557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":6177,"source":{"system":"sec-edgar","filing":"0001062993-22-019276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019276/form4.xml","form_type":"4"}},{"id":2164823,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:07:20.000Z","date":"2022-09-02","kind":"tax_withholding","acquired":false,"shares":150,"price":478.32,"value":71748.0,"ownership":{"direct":true},"balance_after":5620,"source":{"system":"sec-edgar","filing":"0001062993-22-019276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019276/form4.xml","form_type":"4"}},{"id":2164822,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-07T18:07:20.000Z","date":"2022-09-02","kind":"exercise","acquired":true,"shares":433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":5770,"source":{"system":"sec-edgar","filing":"0001062993-22-019276","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019276/form4.xml","form_type":"4"}},{"id":2166844,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2022-09-06T17:46:50.000Z","date":"2022-09-01","kind":"exercise","acquired":false,"shares":405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On September 1, 2021, the reporting person was granted 1,621 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1216,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":405},"source":{"system":"sec-edgar","filing":"0001062993-22-019187","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019187/form4.xml","form_type":"4"}},{"id":2166843,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2022-09-06T17:46:50.000Z","date":"2022-09-01","kind":"grant","acquired":true,"shares":2082,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":2082,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":2082},"source":{"system":"sec-edgar","filing":"0001062993-22-019187","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019187/form4.xml","form_type":"4"}},{"id":2166842,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-06T17:46:50.000Z","date":"2022-09-01","kind":"tax_withholding","acquired":false,"shares":141,"price":486.25,"value":68561.25,"ownership":{"direct":true},"balance_after":5337,"source":{"system":"sec-edgar","filing":"0001062993-22-019187","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019187/form4.xml","form_type":"4"}},{"id":2166841,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2022-09-06T17:46:50.000Z","date":"2022-09-01","kind":"exercise","acquired":true,"shares":405,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":5478,"source":{"system":"sec-edgar","filing":"0001062993-22-019187","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299322019187/form4.xml","form_type":"4"}},{"id":2575511,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2021-09-09T13:38:12.000Z","date":"2021-09-07","kind":"exercise","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On September 7, 2016, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On September 7, 2016, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001062993-21-008414","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008414/form4.xml","form_type":"4"}},{"id":2575510,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-09-09T13:38:12.000Z","date":"2021-09-07","kind":"tax_withholding","acquired":false,"shares":298,"price":806.32,"value":240283.36,"ownership":{"direct":true},"balance_after":5073,"source":{"system":"sec-edgar","filing":"0001062993-21-008414","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008414/form4.xml","form_type":"4"}},{"id":2575509,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-09-09T13:38:12.000Z","date":"2021-09-07","kind":"exercise","acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":5371,"source":{"system":"sec-edgar","filing":"0001062993-21-008414","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008414/form4.xml","form_type":"4"}},{"id":2576799,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2021-09-08T16:10:48.000Z","date":"2021-09-05","kind":"exercise","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 5, 2017, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 5, 2017, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":600,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001062993-21-008358","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008358/form4.xml","form_type":"4"}},{"id":2576798,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2021-09-08T16:10:48.000Z","date":"2021-09-04","kind":"exercise","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"On September 4, 2018, the reporting person was granted 3,000 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1200,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001062993-21-008358","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008358/form4.xml","form_type":"4"}},{"id":2576797,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2021-09-08T16:10:48.000Z","date":"2021-09-03","kind":"exercise","acquired":false,"shares":557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"On September 3, 2019, the reporting person was granted 2,784 restricted stock units, vesting in five equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1671,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":557},"source":{"system":"sec-edgar","filing":"0001062993-21-008358","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008358/form4.xml","form_type":"4"}},{"id":2576796,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-09-08T16:10:48.000Z","date":"2021-09-05","kind":"tax_withholding","acquired":false,"shares":298,"price":819.7,"value":244270.6,"ownership":{"direct":true},"balance_after":4771,"source":{"system":"sec-edgar","filing":"0001062993-21-008358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008358/form4.xml","form_type":"4"}},{"id":2576795,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-09-08T16:10:48.000Z","date":"2021-09-05","kind":"exercise","acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":5069,"source":{"system":"sec-edgar","filing":"0001062993-21-008358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008358/form4.xml","form_type":"4"}},{"id":2576794,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-09-08T16:10:48.000Z","date":"2021-09-04","kind":"tax_withholding","acquired":false,"shares":298,"price":819.7,"value":244270.6,"ownership":{"direct":true},"balance_after":4469,"source":{"system":"sec-edgar","filing":"0001062993-21-008358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008358/form4.xml","form_type":"4"}},{"id":2576793,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-09-08T16:10:48.000Z","date":"2021-09-04","kind":"exercise","acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":4767,"source":{"system":"sec-edgar","filing":"0001062993-21-008358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008358/form4.xml","form_type":"4"}},{"id":2576792,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-09-08T16:10:48.000Z","date":"2021-09-03","kind":"tax_withholding","acquired":false,"shares":277,"price":819.7,"value":227056.9,"ownership":{"direct":true},"balance_after":4167,"source":{"system":"sec-edgar","filing":"0001062993-21-008358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008358/form4.xml","form_type":"4"}},{"id":2576791,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-09-08T16:10:48.000Z","date":"2021-09-03","kind":"exercise","acquired":true,"shares":557,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":4444,"source":{"system":"sec-edgar","filing":"0001062993-21-008358","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008358/form4.xml","form_type":"4"}},{"id":2580787,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2021-09-03T21:09:49.000Z","date":"2021-09-02","kind":"exercise","acquired":false,"shares":433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"On September 2, 2020, the reporting person was granted 1,733 restricted stock units, vesting in four equal annual installments beginning on the first anniversary of the grant date."}],"balance_after":1300,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":433},"source":{"system":"sec-edgar","filing":"0001062993-21-008252","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008252/form4.xml","form_type":"4"}},{"id":2580786,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-09-03T21:09:49.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":1621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The stock option vests over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":1621,"derivative":{"exercise_price":814.95,"expiration_date":"2031-09-01","underlying":"Bio-Rad A Common Stock","underlying_shares":1621},"source":{"system":"sec-edgar","filing":"0001062993-21-008252","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008252/form4.xml","form_type":"4"}},{"id":2580785,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2021-09-03T21:09:49.000Z","date":"2021-09-01","kind":"grant","acquired":true,"shares":1621,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":1621,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1621},"source":{"system":"sec-edgar","filing":"0001062993-21-008252","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008252/form4.xml","form_type":"4"}},{"id":2580784,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-09-03T21:09:49.000Z","date":"2021-09-02","kind":"tax_withholding","acquired":false,"shares":215,"price":825.77,"value":177540.55,"ownership":{"direct":true},"balance_after":3887,"source":{"system":"sec-edgar","filing":"0001062993-21-008252","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008252/form4.xml","form_type":"4"}},{"id":2580783,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-09-03T21:09:49.000Z","date":"2021-09-02","kind":"exercise","acquired":true,"shares":433,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":4102,"source":{"system":"sec-edgar","filing":"0001062993-21-008252","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321008252/form4.xml","form_type":"4"}},{"id":2609673,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-08-10T15:58:29.000Z","date":"2021-08-09","kind":"exercise","acquired":false,"shares":3000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The option, representing a right to purchase a total of 3,000 shares, became exercisable in five equal annual installments beginning on September 11, 2016, which was the first anniversary of the date on which the option was granted."}],"balance_after":0,"derivative":{"exercise_price":139.56,"expiration_date":"2025-09-11","underlying":"Bio-Rad A Common Stock","underlying_shares":3000},"source":{"system":"sec-edgar","filing":"0001062993-21-007240","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321007240/form4.xml","form_type":"4"}},{"id":2609672,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-08-10T15:58:29.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":430,"price":755.72,"value":324959.6,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $755.52 to $756.30, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":3669,"source":{"system":"sec-edgar","filing":"0001062993-21-007240","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321007240/form4.xml","form_type":"4"}},{"id":2609671,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-08-10T15:58:29.000Z","date":"2021-08-09","kind":"sale","acquired":false,"shares":2570,"price":754.8,"value":1939836.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $754.52 to $755.39, inclusive. The reporting person undertakes to provide to Bio-Rad Laboratories, Inc., any security holder of Bio-Rad Laboratories, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":4099,"source":{"system":"sec-edgar","filing":"0001062993-21-007240","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321007240/form4.xml","form_type":"4"}},{"id":2609670,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2021-08-10T15:58:29.000Z","date":"2021-08-09","kind":"exercise","acquired":true,"shares":3000,"price":139.56,"value":418680.0,"ownership":{"direct":true},"balance_after":6669,"source":{"system":"sec-edgar","filing":"0001062993-21-007240","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299321007240/form4.xml","form_type":"4"}},{"id":2941687,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2020-12-17T17:54:10.000Z","date":"2020-12-15","kind":"sale","acquired":false,"shares":374,"price":580.67,"value":217170.58,"ownership":{"direct":true},"balance_after":3669,"source":{"system":"sec-edgar","filing":"0001062993-20-006420","document":"form4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000106299320006420/form4.xml","form_type":"4"}},{"id":3032905,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2020-09-14T22:50:21.000Z","date":"2020-09-11","kind":"exercise","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in five equal annual installments beginning September 11, 2016."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in five equal annual installments beginning September 11, 2016."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001812865-20-000045","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000045/edgar.xml","form_type":"4"}},{"id":3032904,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2020-09-14T22:50:21.000Z","date":"2020-09-11","kind":"tax_withholding","acquired":false,"shares":298,"price":505.02,"value":150495.96,"ownership":{"direct":true},"balance_after":4043,"source":{"system":"sec-edgar","filing":"0001812865-20-000045","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000045/edgar.xml","form_type":"4"}},{"id":3032903,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2020-09-14T22:50:21.000Z","date":"2020-09-11","kind":"exercise","acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":4341,"source":{"system":"sec-edgar","filing":"0001812865-20-000045","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000045/edgar.xml","form_type":"4"}},{"id":3036144,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2020-09-09T17:56:06.000Z","date":"2020-09-07","kind":"exercise","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The restricted stock units vest in five equal annual installments beginning September 7, 2017."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"The restricted stock units vest in five equal annual installments beginning September 7, 2017."}],"balance_after":600,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001812865-20-000035","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000035/edgar.xml","form_type":"4"}},{"id":3036143,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2020-09-09T17:56:06.000Z","date":"2020-09-05","kind":"exercise","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in five equal annual installments beginning September 5, 2018."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in five equal annual installments beginning September 5, 2018."}],"balance_after":1200,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001812865-20-000035","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000035/edgar.xml","form_type":"4"}},{"id":3036142,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2020-09-09T17:56:06.000Z","date":"2020-09-04","kind":"exercise","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in five equal annual installments beginning September 4, 2019."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in five equal annual installments beginning September 4, 2019."}],"balance_after":1800,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001812865-20-000035","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000035/edgar.xml","form_type":"4"}},{"id":3036141,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2020-09-09T17:56:06.000Z","date":"2020-09-07","kind":"tax_withholding","acquired":false,"shares":298,"price":484.23,"value":144300.54,"ownership":{"direct":true},"balance_after":3741,"source":{"system":"sec-edgar","filing":"0001812865-20-000035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000035/edgar.xml","form_type":"4"}},{"id":3036140,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2020-09-09T17:56:06.000Z","date":"2020-09-07","kind":"exercise","acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":4039,"source":{"system":"sec-edgar","filing":"0001812865-20-000035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000035/edgar.xml","form_type":"4"}},{"id":3036139,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2020-09-09T17:56:06.000Z","date":"2020-09-05","kind":"tax_withholding","acquired":false,"shares":226,"price":484.23,"value":109435.98,"ownership":{"direct":true},"balance_after":3439,"source":{"system":"sec-edgar","filing":"0001812865-20-000035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000035/edgar.xml","form_type":"4"}},{"id":3036138,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2020-09-09T17:56:06.000Z","date":"2020-09-05","kind":"exercise","acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":3665,"source":{"system":"sec-edgar","filing":"0001812865-20-000035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000035/edgar.xml","form_type":"4"}},{"id":3036137,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2020-09-09T17:56:06.000Z","date":"2020-09-04","kind":"tax_withholding","acquired":false,"shares":208,"price":484.23,"value":100719.84,"ownership":{"direct":true},"balance_after":3065,"source":{"system":"sec-edgar","filing":"0001812865-20-000035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000035/edgar.xml","form_type":"4"}},{"id":3036136,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2020-09-09T17:56:06.000Z","date":"2020-09-04","kind":"exercise","acquired":true,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":3273,"source":{"system":"sec-edgar","filing":"0001812865-20-000035","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000035/edgar.xml","form_type":"4"}},{"id":3037186,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2020-09-08T16:32:47.000Z","date":"2020-09-03","kind":"exercise","acquired":false,"shares":556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in five equal annual installments beginning September 3, 2020."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in five equal annual installments beginning September 3, 2020."}],"balance_after":2228,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":556},"source":{"system":"sec-edgar","filing":"0001315406-20-000016","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000131540620000016/edgar.xml","form_type":"4"}},{"id":3037185,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2020-09-08T16:32:47.000Z","date":"2020-09-03","kind":"tax_withholding","acquired":false,"shares":193,"price":494.24,"value":95388.32,"ownership":{"direct":true},"balance_after":2673,"source":{"system":"sec-edgar","filing":"0001315406-20-000016","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000131540620000016/edgar.xml","form_type":"4"}},{"id":3037184,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2020-09-08T16:32:47.000Z","date":"2020-09-03","kind":"exercise","acquired":true,"shares":556,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Shares of Class A common stock acquired on the vesting of restricted stock units."}],"balance_after":2866,"source":{"system":"sec-edgar","filing":"0001315406-20-000016","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000131540620000016/edgar.xml","form_type":"4"}},{"id":3038413,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-09-04T19:47:35.000Z","date":"2020-09-02","kind":"grant","acquired":true,"shares":1733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option vests over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":1733,"derivative":{"exercise_price":524.3,"expiration_date":"2030-09-02","underlying":"Bio-Rad A Common Stock","underlying_shares":1733},"source":{"system":"sec-edgar","filing":"0001812865-20-000018","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000018/edgar.xml","form_type":"4"}},{"id":3038412,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2020-09-04T19:47:35.000Z","date":"2020-09-02","kind":"grant","acquired":true,"shares":1733,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The restricted stock units vest over four years at 25% per year on the yearly anniversary date of the grant."}],"balance_after":1733,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":1733},"source":{"system":"sec-edgar","filing":"0001812865-20-000018","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000018/edgar.xml","form_type":"4"}},{"id":3128632,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Bio-Rad A Common Stock","published_at":"2020-06-02T21:11:36.000Z","date":"2020-06-01","kind":"sale","acquired":false,"shares":1500,"price":485.4,"value":728100.0,"ownership":{"direct":true},"balance_after":2310,"source":{"system":"sec-edgar","filing":"0001812865-20-000002","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/12208/000181286520000002/edgar.xml","form_type":"4"}},{"id":3417048,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2019-09-12T19:59:59.000Z","date":"2019-09-11","kind":"exercise","acquired":false,"shares":600,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The restricted stock units vest in five equal annual installments beginning September 11, 2016."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The restricted stock units vest in five equal annual installments beginning September 11, 2016."}],"balance_after":600,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":600},"source":{"system":"sec-edgar","filing":"0001652252-19-000061","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/12208/000165225219000061/edgar.xml","form_type":"4"}},{"id":3417047,"issuer":{"id":2247,"kind":"organization","name":"BIO-RAD LABORATORIES, INC.","symbol":"BIO BIO.B"},"owners":[{"id":81881,"kind":"person","name":"Crowley Michael","position":1,"cik":"0001629381","reported_name":"Crowley Michael","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, GBL Commercial Operations"}}],"security":"Restricted Stock Units","published_at":"2019-09-12T19:59:59.000Z","date":"2019-09-10","kind":"exercise","acquired":false,"shares":389,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The restricted stock units vest in five equal annual installments beginning September 10, 2015."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The restricted stock units vest in five equal annual installments beginning September 10, 2015."}],"balance_after":0,"derivative":{"exercise_price":0,"underlying":"Bio-Rad A Common Stock","underlying_shares":389},"source":{"system":"sec-edgar","filing":"0001652252-19-000061","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/12208/000165225219000061/edgar.xml","form_type":"4"}}],"next_cursor":"2019-09-12T19:59:59.000000Z,3417047"}